Kitada, T., DiAndreth, B., Teague, B. & Weiss, R. Programming gene and engineered-cell therapies with synthetic biology. Science 359, eaad1067 (2018).
Article PubMed PubMed Central Google Scholar
Cubillos-Ruiz, A. et al. Engineering living therapeutics with synthetic biology. Nat. Rev. Drug Discov. 20, 941–960 (2021).
Article CAS PubMed Google Scholar
McNerney, M. P., Doiron, K. E., Ng, T. L., Chang, T. Z. & Silver, P. A. Theranostic cells: emerging clinical applications of synthetic biology. Nat. Rev. Genet. 22, 730–746 (2021).
Article CAS PubMed PubMed Central Google Scholar
Zhang, C., Liu, H., Li, X., Xu, F. & Li, Z. Modularized synthetic biology enabled intelligent biosensors. Trends Biotechnol. 41, 1055–1065 (2023).
Article CAS PubMed Google Scholar
Keasling, J. D. Manufacturing molecules through metabolic engineering. Science 330, 1355–1358 (2010).
Article CAS PubMed Google Scholar
Schmidt, C. K., Medina-Sánchez, M., Edmondson, R. J. & Schmidt, O. G. Engineering microrobots for targeted cancer therapies from a medical perspective. Nat. Commun. 11, 5618 (2020).
Article CAS PubMed PubMed Central Google Scholar
Yang, L., Yang, Y., Chen, Y., Xu, Y. & Peng, J. Cell-based drug delivery systems and their in vivo fate. Adv. Drug Deliv. Rev. 187, 114394 (2022).
Article CAS PubMed Google Scholar
Khalil, A. S. & Collins, J. J. Synthetic biology: applications come of age. Nat. Rev. Genet. 11, 367–379 (2010).
Article CAS PubMed PubMed Central Google Scholar
Voigt, C. A. Synthetic biology 2020–2030: six commercially-available products that are changing our world. Nat. Commun. 11, 6379 (2020).
Article CAS PubMed PubMed Central Google Scholar
Vargason, A. M., Anselmo, A. C. & Mitragotri, S. The evolution of commercial drug delivery technologies. Nat. Biomed. Eng. 5, 951–967 (2021).
Petrus-Reurer, S. et al. Immunological considerations and challenges for regenerative cellular therapies. Commun. Biol. 4, 798 (2021).
Article CAS PubMed PubMed Central Google Scholar
Fenton, O. S., Olafson, K. N., Pillai, P. S., Mitchell, M. J. & Langer, R. Advances in biomaterials for drug delivery. Adv. Mater 30, 1705328 (2018).
Mitchell, M. J. et al. Engineering precision nanoparticles for drug delivery. Nat. Rev. Drug Discov. 20, 101–124 (2021).
Article CAS PubMed Google Scholar
Li, J. & Mooney, D. J. Designing hydrogels for controlled drug delivery. Nat. Rev. Mater. 1, 16071 (2016).
Article CAS PubMed PubMed Central Google Scholar
Senapati, S., Mahanta, A. K., Kumar, S. & Maiti, P. Controlled drug delivery vehicles for cancer treatment and their performance. Signal. Transduct. Target. Ther. 3, 7 (2018).
Article PubMed PubMed Central Google Scholar
Dlugi, A. M., Miller, J. D. & Knittle, J. Lupron depot (leuprolide acetate for depot suspension) in the treatment of endometriosis: a randomized, placebo-controlled, double-blind study. Lupron Study Group. Fertil. Steril. 54, 419–427 (1990).
Article CAS PubMed Google Scholar
Prausnitz, M. R. & Langer, R. Transdermal drug delivery. Nat. Biotechnol. 26, 1261–1268 (2008).
Article CAS PubMed PubMed Central Google Scholar
Mitrousis, N., Fokina, A. & Shoichet, M. S. Biomaterials for cell transplantation. Nat. Rev. Mater. 3, 441–456 (2018).
Sadtler, K. et al. Design, clinical translation and immunological response of biomaterials in regenerative medicine. Nat. Rev. Mater. 1, 16040 (2016).
Rodrigo-Navarro, A., Sankaran, S., Dalby, M. J., del Campo, A. & Salmeron-Sanchez, M. Engineered living biomaterials. Nat. Rev. Mater. 6, 1175–1190 (2021).
Zhao, X. et al. Soft materials by design: unconventional polymer networks give extreme properties. Chem. Rev. 121, 4309–4372 (2021).
Article CAS PubMed PubMed Central Google Scholar
Darnell, M. & Mooney, D. J. Leveraging advances in biology to design biomaterials. Nat. Mater. 16, 1178–1185 (2017).
Article CAS PubMed Google Scholar
Kharbikar, B. N., Mohindra, P. & Desai, T. A. Biomaterials to enhance stem cell transplantation. Cell Stem Cell 29, 692–721 (2022).
Article CAS PubMed PubMed Central Google Scholar
Rowan, M. P. et al. Burn wound healing and treatment: review and advancements. Crit. Care 19, 243 (2015).
Article PubMed PubMed Central Google Scholar
Li, D. et al. Genetically engineered T cells for cancer immunotherapy. Signal. Transduct. Target. Ther. 4, 35 (2019).
Article PubMed PubMed Central Google Scholar
Pettenati, C. & Ingersoll, M. A. Mechanisms of BCG immunotherapy and its outlook for bladder cancer. Nat. Rev. Urol. 15, 615–625 (2018).
Article CAS PubMed Google Scholar
Swanson, K. S. et al. The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of synbiotics. Nat. Rev. Gastroenterol. Hepatol. 17, 687–701 (2020).
Article PubMed PubMed Central Google Scholar
Zhao, Z., Anselmo, A. C. & Mitragotri, S. Viral vector-based gene therapies in the clinic. Bioeng. Transl. Med. 7, e10258 (2022).
Pol, J., Kroemer, G. & Galluzzi, L. First oncolytic virus approved for melanoma immunotherapy. Oncoimmunology 5, e1115641 (2016).
Cooper, C. J., Khan Mirzaei, M. & Nilsson, A. S. Adapting drug approval pathways for bacteriophage-based therapeutics. Front. Microbiol. 7, 1209 (2016).
Article PubMed PubMed Central Google Scholar
Bashor, C. J., Hilton, I. B., Bandukwala, H., Smith, D. M. & Veiseh, O. Engineering the next generation of cell-based therapeutics. Nat. Rev. Drug Discov. 21, 655–675 (2022).
Article CAS PubMed PubMed Central Google Scholar
Strathdee, S. A., Hatfull, G. F., Mutalik, V. K. & Schooley, R. T. Phage therapy: from biological mechanisms to future directions. Cell 186, 17–31 (2023).
留言 (0)